"[H]its a stunning home run every time"
- Chambers Global

Over the last several years, Cadwalader has emerged as one of the leading mergers and acquisitions firms in the country. Our nationally recognized team of attorneys has been called on to handle some of the largest and most complex deals in the marketplace, and has compiled an impressive record of recent transactions. The last several years have seen Cadwalader act as counsel in such noteworthy transactions as:

• DPL Inc. in its $4.7 billion sale to AES Corp.
• Pfizer Inc. in the $2.38 billion sale of its Capsugel unit to private equity group Kohlberg Kravis Roberts & Co.
• The Renco Group's $1.2 billion stock purchase of three steel companies from Russian-based OAO Severstal through its wholly-owned subsidiary RG Steel
• Procter & Gamble in its recently announced $2.35 billion sale of the Pringles brand to Diamond Foods
• Pfizer Inc.'s pending acquisition of King Pharmaceuticals, Inc.
• Pfizer's acquisition of Wyeth
• Bear Stearns acquisition by JP Morgan Chase
• Pfizer's sale of its consumer healthcare business to Johnson & Johnson
• The Procter & Gamble Company's acquisition of The Gillette Company
• Pfizer's acquisition of Pharmacia
• Pfizer's acquisition of Warner-Lambert
• Sale of Quaker Oats to PepsiCo
• Sale of Schick-Wilkinson to Energizer
• Sale of the Adam's Confectionary division of Pfizer to Cadbury Schweppes
• Sale of Storage Tek to Sun Microsystems
• Pfizer's acquisition of Vicuron Pharmaceuticals

Cadwalader’s leading M&A attorneys are recognized for providing clients not only with loyalty, focus and commitment, but also with the sophisticated legal and business expertise needed to achieve their goals — always with the creativity, flexibility and timeliness required in today’s competitive environment. Our M&A partners are consistently recognized by independent commentators as some of the lead deal-makers in the country. Our clients – buyers, sellers and investment banks — are a veritable "who’s who" of corporations and financial institutions, including: domestic and international public and private companies ranging from entrepreneurial start-ups to mature multinational corporations operating in virtually every industry and service sector; and significant financial institutions, including commercial and investment banks, brokerage houses, insurance companies, pension funds and venture capital funds.

Providing assistance beginning at the earliest stages of a transaction, Cadwalader attorneys advise clients in evaluating and developing alternative strategies for achieving business objectives, structuring and documenting deals, arranging financing, and obtaining regulatory approvals. We are known for our ability to structure and coordinate creative and complex transaction structures with long-term tax benefits, operating efficiencies, and enhanced rate of return and for our expertise in the areas of law that frequently affect mergers and acquisitions, such as antitrust; environmental; employee benefits; financial restructuring and insolvency; international and domestic tax; litigation; and securitization. In addition, we are proficient at coordinating and guiding other professionals, such as investment bankers, accountants, and actuaries, to complete transactions efficiently and effectively.

Other Recent Transactions

Pfizer Inc. Acquisition of Warner-Lambert Co. $114.5 billion   U S West Global Crossing merger agreement $70 billion   Pfizer Inc. Acquisition of Pharmacia Corporation $62.5 billion   The Procter & Gamble Company Acquisition of The Gillette Company $57 billion   Lehman Brothers CVS Corporation acquisition of Embrex Inc. $21 billion

Pfizer Inc. Sale of Consumer Healthcare Business to Johnson & Johnson $16.6 billion   Quaker Oats Company Acquired by PepsiCo, Inc. $14 billion   Pfizer Inc. Sale of candy unit to Cadbury Schweppes $4.2 billion   Storage Tek Acquired by Sun Microsystems $4.1 billion   Bear Stearns Shire plc acquisition of New River Pharmaceuticals, Inc $2.6 billion

Pfizer Acquisition of Vicuron Pharmaceuticals $1.9 billion   Pfizer Inc. Sale of Schick-Wilkinson Sword to Energizer Holdings, Inc. $930 million   Six Flags Theme Parks Sale of CNL Income Properties Inc Parc 7F $312 million   Pfizer Inc. (Animal Health Division) Acquisition of Embrex Inc. $165.4 million